Oesophageal Acid Exposure in Healthy Subjects Over 96 Hours
Measurement of Acid Exposure in Healthy Subjects Using 96 Hours Wireless pH Monitoring (Bravo™)
1 other identifier
interventional
50
1 country
2
Brief Summary
First introduced over 40 years ago, the 24-hour catheter-based pH studies have previously been found to be the gold standard in the diagnosis of gastro-oesophageal reflux disease (GORD). In 2003, the Bravo has revolutionised the study of GORD, allowing patients an improved comfort and ability to perform activities of daily living. The backflow of gastric acid (acid exposure) in the oesophagus is monitored by a tiny pH sensor located in a capsule which is pinned temporarily to the wall of the oesophagus at the time of endoscopy. Normal measurements for acid exposure are established for 48-hour studies. However, the investigators' studies have shown that extending the duration of recording to 96 hours further improved the diagnostic yield for GORD in patients with negative 24-hour catheter-based tests The 96-hour recording is the current standard of care, despite the lack of normal ranges for this duration of the recording. The basis for the diagnosis of GORD in 96-hours studies is based on the 48-hours normal controls. The objective of this study is to determine the normal values for oesophageal acid exposure using the wireless pH recording apparatus over 96 hours in asymptomatic healthy subjects with unrestricted activity and diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2018
CompletedFirst Posted
Study publicly available on registry
January 31, 2018
CompletedStudy Start
First participant enrolled
October 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedAugust 21, 2019
August 1, 2019
9 months
January 8, 2018
August 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Acid exposure time in 4 days/96 hours
4 days
Secondary Outcomes (8)
Acid exposure time in 3 days/72 hours
3 days
Percent total time pH < 4 for each 24-hour period
1 day
Percent Upright time pH < 4 for each 24-hour period
1 day
Percent Supine time pH < 4 for each 24-hour period
1 day
Number of reflux episodes for each 24-hour period
1 day
- +3 more secondary outcomes
Study Arms (1)
Healthy subjects
OTHERBravo wireless pH monitoring over 96 hours
Interventions
Eligibility Criteria
You may qualify if:
- Asymptomatic in:
- GORD according to the Montreal GORD consensus definition
- Dysphagia using the Hospital Odynophagia Dysphagia Questionnaire (HODQ) scoring \< 7
- People without reflux referred for gastroscopy in context of other conditions e.g. iron deficiency anaemia, coeliac disease.
- Subjects must sign an informed consent
You may not qualify if:
- Gastro-oesophageal symptoms in accordance with Montreal criteria
- Previous abdominal operations on GI tract
- Antireflux treatments either prescribed or over the counter
- BMI \> 35
- History of hepatic diseases, oesophageal varices
- History of ischemic heart disease, asthma
- Anticoagulants
- Allergies
- Pregnancy
- Any medical or non-medical condition that in the opinion of the research team will make the candidate unfit for this study e.g. drug abuse etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Guy's and St Thomas' NHS Foundation Trust
London, SE1 7EH, United Kingdom
King's College London
London, WC2R 2LS, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Terry Wong, MA MD
Consultant Gastroenterologist, Guy's and St Thomas' NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2018
First Posted
January 31, 2018
Study Start
October 16, 2018
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
August 21, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share